BB BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.3 EUR | -0.23% |
|
+4.97% | -4.84% |
| Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
| Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Evolution of the average Target Price on BB Biotech AG
Price target over the last 5 years
History of analyst recommendation changes
3a93045faaf8fd800559c823699e380.Xr_qKLsb1z6wKmpWWXF681vlwjTJmKvANx9XhvB8AtQ.B9yDGdh3oHL2ZkcROhwWogipu2KGysCXeUcn9JEzS5wwjowZjyOwZ9R_Iw~fa6a11adee9588e63dfc75386c930f13
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.4
CHF
Average target price
47.7
CHF
Spread / Average Target
+12.50%
High Price Target
47.7
CHF
Spread / Highest target
+12.50%
Low Price Target
47.7
CHF
Spread / Lowest Target
+12.50%
Consensus detail
Consensus revision (last 18 months)
Analysts covering BB Biotech AG
| BAADER BANK | |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- BION Stock
- BBZA Stock
- Consensus BB Biotech AG
